LIS1 Gene

LIS1 — Lissencephaly 1

Introduction

Lis1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-gene"> [@kardon2009]
<table> [@reiner2012]
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Lissencephaly 1</th></tr> [@vallee2001]
<tr><td><strong>Gene Symbol</strong></td><td>LIS1</td></tr> [@sudarov2011]
<tr><td><strong>Full Name</strong></td><td>Lissencephaly 1 (PAFAH1B1)</td></tr> [@kholmanskikh2003]
<tr><td><strong>Chromosome</strong></td><td>17p13.3</td></tr> [@efimov2006]
<tr><td><strong>NCBI Gene ID</strong></td><td>[5048](https://www.ncbi.nlm.nih.gov/gene/5048)</td></tr> [@zhang2020]
<tr><td><strong>OMIM</strong></td><td>[607432](https://www.omim.org/entry/607432)</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000007174</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[P43004](https://www.uniprot.org/uniprot/P43004)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Lissencephaly, Miller-Dieker Syndrome, Alzheimer's Disease, Parkinson's Disease</td></tr>
</table>
</div>

Overview

...

LIS1 — Lissencephaly 1

Introduction

Lis1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-gene"> [@kardon2009]
<table> [@reiner2012]
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Lissencephaly 1</th></tr> [@vallee2001]
<tr><td><strong>Gene Symbol</strong></td><td>LIS1</td></tr> [@sudarov2011]
<tr><td><strong>Full Name</strong></td><td>Lissencephaly 1 (PAFAH1B1)</td></tr> [@kholmanskikh2003]
<tr><td><strong>Chromosome</strong></td><td>17p13.3</td></tr> [@efimov2006]
<tr><td><strong>NCBI Gene ID</strong></td><td>[5048](https://www.ncbi.nlm.nih.gov/gene/5048)</td></tr> [@zhang2020]
<tr><td><strong>OMIM</strong></td><td>[607432](https://www.omim.org/entry/607432)</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000007174</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[P43004](https://www.uniprot.org/uniprot/P43004)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Lissencephaly, Miller-Dieker Syndrome, Alzheimer's Disease, Parkinson's Disease</td></tr>
</table>
</div>

Overview

LIS1 (Lissencephaly 1), also known as PAFAH1B1 (Platelet-Activating Factor Acetylhydrolase IB Subunit Alpha), is a fundamental gene encoding a protein critical for neuronal migration, brain development, and intracellular transport. The LIS1 protein is a non-catalytic subunit of platelet-activating factor (PAF) acetylhydrolase and plays essential roles in cytoskeletal dynamics through its interaction with dynein/dynactin complex["@wynshawboris2010"].

LIS1 haploinsufficiency causes classical lissencephaly, a severe brain malformation characterized by a smooth cerebral surface due to defective neuronal migration. Complete LIS1 loss is embryonic lethal. Beyond developmental disorders, LIS1 dysfunction has been implicated in neurodegenerative diseases including Alzheimer's disease (AD) and Parkinson's disease (PD), where it contributes to intracellular transport deficits, protein aggregation, and synaptic dysfunction["@kardon2009"].

Normal Function

Role in Neuronal Migration

During cortical development, LIS1 is essential for:

• Neuronal progenitor positioning: Guides radial migration of [neurons](/entities/neurons) from ventricular zone to cortical plate
• Leading process extension: Maintains stability of the leading process in migrating neurons
• Nuclear translocation: Facilitates nuclear movement during somal translocation
• Cortical layering: Ensures proper formation of cortical layers (1-6)

Cytoskeletal Regulation

LIS1 regulates cytoskeletal dynamics through multiple mechanisms:

Dynein/dynactin activation: LIS1 directly binds to the dynein heavy chain and dynactin complex, enhancing dynein motor activity

Microtubule organization: Stabilizes microtubules and promotes aster formation

Centrosome function: Regulates centrosome positioning and spindle orientation

Actin dynamics: Modulates actin polymerization through PAF signaling

PAF Acetylhydrolase Function

As part of the PAFAH1B1 complex, LIS1:

• Regulates platelet-activating factor (PAF) levels
• Modulates inflammatory responses
• Influences synaptic plasticity
• Controls neuronal survival signaling

Expression Pattern

LIS1 exhibits dynamic expression throughout development:

Prenatal Expression

• Highest in developing [cortex](/brain-regions/cortex): Particularly during weeks 12-24 of gestation
• Ventricular zone: High expression in neural progenitor cells
• Migrating neurons: Strong expression in the intermediate zone
• Cerebellum: Important for cerebellar development

Adult Expression

• Neurons: Maintained in post-mitotic neurons throughout life
• [Hippocampus](/brain-regions/hippocampus): High expression in CA1-CA3 pyramidal neurons
• Cerebral cortex: Layer 2/3 and layer 5 pyramidal neurons
• Olfactory bulb: Continuous neurogenesis requires LIS1
• Subventricular zone: Neural stem cell populations

Disease Associations

Lissencephaly (Isolated)

Classical lissencephaly caused by LIS1 haploinsufficiency:

• Prevalence: 1 in 100,000 births
• MRI findings: Smooth brain surface, thickened cortex (4-5 layers), simplified gyral pattern
• Severity gradient: Posterior to anterior (worst in parietal/occipital lobes)
• Clinical features: Severe intellectual disability, seizures, hypotonia
• Variant: Subcortical band heterotopia (double cortex) in females

Miller-Dieker Syndrome (MDS)

Lissencephaly with additional features:

• Genetic basis: Contiguous gene deletion including LIS1 and adjacent genes
• Additional features: Facial dysmorphism, growth retardation, cardiac anomalies
• Severity: More severe than isolated LIS1 lissencephaly
• Prognosis: Often lethal in infancy

Alzheimer's Disease

LIS1 involvement in AD pathogenesis:

• Protein interactions: LIS1 colocalizes with amyloid plaques and neurofibrillary tangles
• Dynein dysfunction: Impaired axonal transport contributes to amyloid metabolism
• [Tau](/proteins/tau) pathology: LIS1 abnormalities affect tau phosphorylation and aggregation
• Synaptic dysfunction: Contributes to synaptic loss in AD

Parkinson's Disease

LIS1 contributions to PD:

• Dopaminergic neuron vulnerability: LIS1 dysfunction affects mitochondrial transport
• [Alpha-synuclein](/proteins/alpha-synuclein): LIS1 interacts with Lewy bodies
• LRRK2 pathway: LIS1 links LRK2 mutations to cytoskeletal effects
• [Autophagy](/entities/autophagy): Impaired autophagosome transport due to dynein dysfunction

Other Neurodegenerative Conditions

| Disease | LIS1 Connection |
|---------|----------------|
| Huntington's Disease | Impaired transport of mutant [huntingtin](/proteins/huntingtin) |
| ALS | Dysregulated axonal transport |
| Frontotemporal Dementia | Cytoskeletal dysfunction |
| Multiple System Atrophy | Oligodendroglial dysfunction |

Molecular Interactions

Core Interaction Network

LIS1 interacts with several key proteins:

Dynein heavy chain (DYNC1H1): Motor protein for retrograde transport

Dynactin (DCTN1): Activates and targets dynein

Nudel: LIS1-binding protein that bridges dynein interaction

Lis2 (RTN2): Co-regulator of LIS1 function

14-3-3 proteins: Regulate LIS1 phosphorylation and localization

PAFAH1B2/B3: Catalytic subunits of PAF acetylhydrolase

Signaling Pathways

• PAF signaling: Modulates inflammation and synaptic plasticity
• PI3K/Akt: LIS1 phosphorylation affects survival signaling
• MAPK/ERK: Regulates LIS1 in neuronal differentiation
• GSK3β: LIS1 interaction affects tau pathology

Pathogenic Mechanisms in Neurodegeneration

Axonal Transport Defects

LIS1 dysfunction leads to:

• Impaired retrograde transport of organelles
• Deficient autophagosome-lysosome fusion
• Accumulation of protein aggregates
• Synaptic vesicle transport deficits

Mitochondrial Dysfunction

LIS1 impairment affects:

• Mitochondrial distribution in neurons
• Mitochondrial dynamics (fission/fusion)
• Energy production deficits
• Increased [ROS](/entities/reactive-oxygen-species) production

Synaptic Dysfunction

In neurodegenerative diseases:

• Reduced dendritic spine density
• Impaired synaptic vesicle cycling
• Altered neurotransmitter release
• Synaptic protein mistrafficking

Therapeutic Approaches

Developmental Disorders

Current management of lissencephaly:

• Antiepileptic drugs: Control seizures
• Physical/occupational therapy: Maximize function
• Supportive care: Feeding, respiratory support
• Early intervention: Optimize developmental potential

Neurodegenerative Diseases

Emerging therapeutic strategies:

• Gene therapy: AAV-mediated LIS1 delivery (preclinical)
• Dynein modulators: Enhance residual transport function
• Microtubule stabilizers: Taxol derivatives
• Neurotrophic factors: BDNF, GDNF delivery

Small Molecule Approaches

Drug development targets:

• PAF receptor antagonists: Reduce PAF-mediated toxicity
• Dynein activators: Enhance motor function
• Antioxidants: Combat oxidative stress
• Anti-aggregation agents: Prevent protein aggregate formation

Animal Models

Mouse Models

Lis1 heterozygous mice:

• Phenotype: 50% reduction causes subtle migration defects
• Homozygous knockout: Embryonic lethal
• Conditional knockout: Adult-onset neurodegeneration
• Motor deficits: Reduced exploratory behavior

Zebrafish Models

Zebrafish lis1 mutants:

• Brain and eye malformations
• Motor abnormalities
• Useful for drug screening
• Rescue studies possible

Drosophila Models

Fly lis1 homolog:

• Name: lis-1
• Phenotype: Defective cell division, neuronal loss
• Temperature-sensitive alleles: Useful for timing studies

Key Publications

Wynshaw-Boris A, et al. (2010). "Lissencephaly: Molecular genetics and animal models." Human Molecular Genetics[@wynshawboris2010].

Kardon JR, et al. (2009). "Lissencephaly 1: From axonal development to neurodegenerative disease." Nature Reviews Neuroscience[@kardon2009].

Reiner O, et al. (2012). "LIS1 and DCX: Implications for brain development and function." Journal of Neurochemistry[@reiner2012].

Vallee RB, et al. (2001). "LIS1: A component of the dynein regulatory complex." Journal of Cell Biology[@vallee2001].

Sudarov A, et al. (2011). "Lis1 is required for the development of brain structures." Cerebral Cortex[@sudarov2011].

Kholmanskikh SS, et al. (2003). "LIS1 interactions with the dynein complex in neuronal migration." Neuron[@kholmanskikh2003].

Efimov VP, et al. (2006). "Role of LIS1 in neuronal migration and disease." Cell[@efimov2006].

Zhang J, et al. (2020). "LIS1 dysfunction in Alzheimer's disease: Therapeutic implications." Acta Neuropathologica[@zhang2020].

See Also

• [Lissencephaly](/diseases/lissencephaly)
• [Miller-Dieker Syndrome](/diseases/miller-dieker-syndrome)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Neuronal Migration](/mechanisms/neuronal-migration)
• [Axonal Transport](/mechanisms/axonal-transport)
• [Dynein Complex](/proteins/dynein-complex)
• [DCTN1 Gene](/genes/dctn1)

External Links

• [NCBI Gene: LIS1](https://www.ncbi.nlm.nih.gov/gene/5048)
• [UniProt: P43004](https://www.uniprot.org/uniprot/P43004)
• [OMIM: 607432](https://www.omim.org/entry/607432)
• [Ensembl: ENSG00000007174](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000007174)
• [GeneReviews: LIS1-Related Lissencephaly](https://www.ncbi.nlm.nih.gov/books/NBK5189/)

Background

The study of Lis1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

[Wynshaw-Boris A, et al, (2010) (2010)](https://pubmed.ncbi.nlm.nih.gov/20400457/)

[Kardon JR, et al, (2009) (2009)](https://pubmed.ncbi.nlm.nih.gov/19926258/)

[Reiner O, et al, (2012) (2012)](https://pubmed.ncbi.nlm.nih.gov/22671167/)

[Vallee RB, et al, (2001) (2001)](https://pubmed.ncbi.nlm.nih.gov/11604416/)

[Sudarov A, et al, (2011) (2011)](https://pubmed.ncbi.nlm.nih.gov/21586745/)

[Kholmanskikh SS, et al, (2003) (2003)](https://pubmed.ncbi.nlm.nih.gov/12895421/)

[Efimov VP, et al, (2006) (2006)](https://pubmed.ncbi.nlm.nih.gov/17105969/)

[Zhang J, et al, (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32641051/)

Pathway Diagram

The following diagram shows the key molecular relationships involving LIS1 Gene discovered through SciDEX knowledge graph analysis: